MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

Clinical trial NCT04895735 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04895735
Sponsor: Mayo Clinic
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Salivary Gland Carcinoma Recurrent Salivary Gland Carcinoma Stage IV Major Salivary Gland Cancer AJCC v8 Adenoid Cystic Carcinoma

Start date: 2021-07-23
Primary completion: 2025-08-13
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.